Literature DB >> 23237817

Effect of subcutaneous epinephrine/saline/local anesthetic versus saline-only injection on split-thickness skin graft donor site perfusion, healing, and pain.

Sigrid Blome-Eberwein1, Michael Abboud, Daniel D Lozano, Rohit Sharma, Sherrine Eid, Christina Gogal.   

Abstract

The technique for split-thickness skin graft harvest varies among surgeons. Even though there is scientific evidence that the subcutaneous injection of modified tumescent solution reduces blood loss during burn surgery, the technique has not been unanimously adapted because of, in part, fear of healing retardation. This study prospectively examines the effect of tumescent injection on donor site perfusion, healing, and pain. Ten burn patients in need of grafting with a need for two distinctly different donor sites were included. During the grafting procedure, the two donor areas were randomly assigned to receive either modified tumescent solution or warm sterile saline solution subcutaneously before skin graft harvest with a dermatome. Perfusion, pain, pruritus, and donor site healing were measured, and a follow-up evaluation on scar quality was performed. Baseline perfusion on day 1 was significantly less in the donor site injected with modified tumescent solution (62.26 vs 95.71 perfusion units; P = .031), whereas the response to heat was similar in both sites. The physiologic response to injury (hyperemia) on days 2 and 3 was not suppressed in the modified tumescent group. Pain reported on day 1 was 2.38/10 in the tumescent site and 3.38/10 in the saline site (P = .21). On all other days, measurements showed no difference between the two sites. Donor sites healed in an average of 16.1 days with modified tumescent solution and in 16.4 days with saline. Late follow-up showed no difference in scar quality. The subcutaneous injection of modified tumescent solution before split-thickness donor site harvest has no adverse effect on donor site perfusion past day 1 or donor site healing. The addition of a local anesthetic may decrease pain for 24 hours postoperatively, but the difference in this study group was not significant. This technique should be universally recommended.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23237817     DOI: 10.1097/BCR.0b013e31825d5414

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  8 in total

1.  Effectiveness of collagen/oxidised regenerated cellulose/silver-containing composite wound dressing for the treatment of medium-depth split-thickness skin graft donor site wounds in multi-morbid patients: a prospective, non-comparative, single-centre study.

Authors:  Alexander Konstantinow; Tatjana V Fischer; Johannes Ring
Journal:  Int Wound J       Date:  2016-12-01       Impact factor: 3.315

2.  Ultrasound-Guided Regional Anesthesia for Pediatric Burn Reconstructive Surgery: A Prospective Study.

Authors:  Erik S Shank; Jeevendra A Martyn; Mathias B Donelan; Anthony Perrone; Paul G Firth; Daniel N Driscoll
Journal:  J Burn Care Res       Date:  2016 May-Jun       Impact factor: 1.845

Review 3.  Regional Anesthetic Blocks for Donor Site Pain in Burn Patients: A Meta-Analysis on Efficacy, Outcomes, and Cost.

Authors:  Katherine A Grunzweig; Ji Son; Anand R Kumar
Journal:  Plast Surg (Oakv)       Date:  2020-06-10       Impact factor: 0.947

4.  Effect of Subcutaneous Adrenaline/Saline/Lidocaine Injection on Split-Thickness Skin Graft Donor Site Wound Healing.

Authors:  Kohei Fukuoka; Shunjiro Yagi; Yoshiko Suyama; Wataru Kaida; Maki Morita; Ichiro Hisatome
Journal:  Yonago Acta Med       Date:  2021-02-01       Impact factor: 1.641

5.  Reduction of pain via platelet-rich plasma in split-thickness skin graft donor sites: a series of matched pairs.

Authors:  John D Miller; Timothy M Rankin; Natalie T Hua; Tina Ontiveros; Nicholas A Giovinco; Joseph L Mills; David G Armstrong
Journal:  Diabet Foot Ankle       Date:  2015-01-22

6.  Estimated Maximal Safe Dosages of Tumescent Lidocaine.

Authors:  Jeffrey A Klein; Daniel R Jeske
Journal:  Anesth Analg       Date:  2016-05       Impact factor: 5.108

7.  Prevention of Surgical Site Infections and Biofilms: Pharmacokinetics of Subcutaneous Cefazolin and Metronidazole in a Tumescent Lidocaine Solution.

Authors:  Jeffrey A Klein; Loralie J Langman
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-05-30

8.  Systematic review of clinical outcome reporting in randomised controlled trials of burn care.

Authors:  Amber E Young; Anna Davies; Sophie Bland; Sara Brookes; Jane M Blazeby
Journal:  BMJ Open       Date:  2019-02-15       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.